BridgeBio · 17 hours ago
Sr. Manager, Patient Advocacy
United States
Full-time
Remote
Mid, Senior Level
$167K/yr - $206K/yr
2+ years expBridgeBio is a company focused on developing groundbreaking advancements in rare diseases and life-changing medicines. They are seeking a Senior Manager of Global Patient Advocacy to engage with patients, families, and community advocates to enhance the drug development process and foster strong relationships with advocacy organizations.
BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
Responsibilities
Inspire a patient-first mentality by communicating the “voice of the patient/caregiver” to internal teams and incorporating patient stories, imagery, and unmet needs in company activities and materials
Act with honesty, integrity, and transparency in collaboration with patients and patient organizations
Establish and/or further develop and continuously strengthen advocacy relationships with patient advocacy organizations globally through compliant and thoughtful engagement and alignment on company priorities
Develop and implement patient advocacy communication platforms and activities by collaborating with internal teams that include development, operations, medical, legal, compliance, communications, and commercial
Support the planning and organization of external meetings and events according to requirements, target audience, and objectives
Provide logistical and operational support to the grant and sponsorship processes
Manage financial and reimbursement activities to support meetings with external patient and medical community members (ie, Community Advisory Board and Task Force Meetings)
Qualification
Required
Bachelor's degree (or higher) in a relevant life science field is required; a post-graduate degree in counseling, social work, genetic counseling, public health, nursing, pharmacy, or life sciences is strongly valued
Demonstrated ability to build relationships with patient advocacy organizations, professional associations, or other stakeholders is required
Ability to travel up to 30% (often on weekends) is required
Preferred
Experience in rare disease or endocrine disease is preferred
A minimum of 2 years in patient advocacy/advocacy relations, or a similar function in an industry role, is preferred
Communicative ability in a second language would be highly valuable
Benefits
401K with 100% employer match on first 3% & 50% on the next 2%
Employee stock purchase program
Pre-tax commuter benefits
Referral program with $2,500 award for hired referrals
Comprehensive health care with 100% premiums covered - no cost to you and dependents
Mental health support via Spring Health (6 therapy sessions & 6 coaching sessions)
Hybrid work model - employees have the autonomy in where and how they do their work
Unlimited flexible paid time off - take the time that you need
Paid parental leave - 4 months for birthing parents & 2 months for non-birthing parents
Flex spending accounts & company-provided group term life & disability
Subsidized lunch via Forkable on days worked from our office
People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility
We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, Spring Health & BetterUp Coaching
We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities
Company
BridgeBio
BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.
201-500 employees
H1B Sponsorship
BridgeBio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (5)
2023 (4)
2022 (4)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$4.9BKey Investors
Blue OwlQatar Investment AuthorityKohlberg Kravis Roberts
2026-01-16Debt Financing· $550M
2025-02-25Post Ipo Debt· $500M
2024-03-04Post Ipo Equity· $250M
Leadership Team
Justin To
CEO, Skeletal Dysplasias (QED Therapeutics)
Neil Kumar
CEO and Founder
Recent News
BioWorld Financial Watch
2026-01-17
Company data provided by crunchbase